Blood–brain barrier dysfunction can contribute to pharmacoresistance of seizures

Seda Salar, Anna Maslarova, Kristina Lippmann, Julia Herzig-Nichtweiß, Itai Weissberg, Liron Sheintuch, Wolfram S. Kunz, Zamir Shorer, Alon Friedman, Uwe HeinemannEpilepsia 2014 · DOI

Abstract

A dysfunctional BBB with acute extravasation of serum albumin into the brain's interstitial space could contribute to pharmacoresistance. In such instances, choice of an AED with low albumin binding affinity may help in seizure control.
BibTeX
@inproceedings{salar2014bloodbrain,
  author = {Seda Salar and Anna Maslarova and Kristina Lippmann and Julia Herzig-Nichtweiß and Itai Weissberg and Liron Sheintuch and Wolfram S. Kunz and Zamir Shorer and Alon Friedman and Uwe Heinemann},
  title = {{Blood–brain barrier dysfunction can contribute to pharmacoresistance of seizures}},
  booktitle = {Epilepsia},
  year = {2014},
  doi = {10.1111/epi.12713},
}

Loading related content...

Figure